Skip to main content
Skip to footer
Home
Home
About
Overview
Management Team
Board of Directors
Medical & Scientific Advisors
Pipeline
Overview
NP-120 (Ifenprodil)
NP-251 (Repirinast)
AP-188 (DMT)
Companies
Algernon NeuroScience
News & Media
News Releases
IR Calendar
Presentations
Videos/Articles
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEDAR
Governance
Contact
SEC Filings
Investors
Investors
Overview
News & Events
Overview
News Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual General Meeting
Analysts
Stock Data
CSE:AGN
OTCQB:AGNPF
XFRA:AGW0
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
D
DRS
DRS/A
F-1
F-1/A
FWP
RW
Year:
View All
2022
2021
2020
2018
2016
2015
Date
Form
Description
PDF
XBRL
Pages
12/21/22
RW
Registration Withdrawal Request
2
06/03/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-1.1
EX-4.2
EX-5.1
EX-5.2
EX-8.1
EX-23.1
EX-FILING FEES
275
05/10/22
FWP
Filing under Securities Act Rules 163/433 of free writing prospectuses
26
05/09/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-23.1
EX-FILING FEES
201
04/25/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-1.1
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-5.1
EX-5.2
EX-8.1
EX-23.1
EX-FILING FEES
332
04/15/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-23.1
197
04/06/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-23.1
197
03/24/22
F-1/A
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-3.2
EX-23.1
EX-99.4
EX-99.5
288
02/22/22
F-1
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-3.1
EX-3.2
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-14.1
EX-21.1
EX-23.1
EX-99.1
EX-99.2
EX-99.3
EX-FILING FEES
731
01/21/22
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
expand_more
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
635
rss_feed
Filing RSS
Page
1
Page
2
Next Page
arrow_forward
Facebook
Twitter
LinkedIn
Email Alerts
Email Alerts
Contacts
RSS News Feed